Atlas Trials

Phase 3 Study of Sofosbuvir and Ribavirin

Clinical trial NCT01497366 · COMPLETED

Trial details

NCT number
NCT01497366
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2011-12-01
Primary completion
2013-01-01
Enrollment
527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.